NCT04399655

Brief Summary

Chronic hemodialysis is often associated with a reduction in the quality of life of patients and a reduction in physical activity, due to the repeated frequency of sessions. Various studies conducted in hemodialysis patients have shown the beneficial effects of physical exercise during hemodialysis sessions on reducing cardiovascular risk, the number of hospitalizations and improving quality of life. It also contributes to improved patient adherence to care. Finally, it has been shown that exercise during the hemodialysis session is safe for the patient and does not disrupt dialysis parameters. Nevertheless, there are no data on the medico-economic impact of such a program. Based on the investigators' experience, the investigators have developed a specific protocol linking the different types of physical activity that have provided evidence of their efficiency and used in standard practice in the investigators' institutions. From tests and questionnaires assessing the physical abilities of patients have already validated for this population in this pathology. The objective of this project is to show the medico-economic interest of an adapted physical activity program for hemodialysis patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 11, 2020

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 22, 2020

Completed
6 months until next milestone

Study Start

First participant enrolled

November 12, 2020

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 4, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 4, 2022

Completed
Last Updated

November 16, 2022

Status Verified

June 1, 2022

Enrollment Period

1.6 years

First QC Date

May 11, 2020

Last Update Submit

November 15, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Variation in direct and indirect medical costs

    Evaluation of medical costs between the 12 months prior to the start of the adapted physical activity program and the 12 months following the start of the adapted physical activity program.

    through study completion, an average of 1 year

Secondary Outcomes (11)

  • change in the quality of life score

    baseline, at 6 months and at one year

  • change in body mass index, weight and height will be combined to report BMI in kg/m^2

    every month, up to 12 months

  • change in blood presure in mmHg

    every month, up to 12 months

  • change in rate of haemoglobin in g/dL

    every month, up to 12 months

  • change in percentage of hematocrit and saturation coefficient in %

    every month, up to 12 months

  • +6 more secondary outcomes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Haemodialysis patient, of full age, for more than 12 months and in front of benefiting/benefiting from a physical activity program

You may qualify if:

  • Patient dependent on the CPAM Haute Garonne,
  • Patient affiliated to or beneficiary of a French social security scheme,
  • Haemodialysis patient for more than 12 months and in front of benefiting/benefiting from a physical activity program,
  • Patient age ≥ at 18 years old,
  • French speaking patient.

You may not qualify if:

  • Patient with cancer, hepatitis, stage 4 arterial disease, arteritis or amputation of a limb
  • Pregnant or breastfeeding women according to article L.1121-5 of the CSP,
  • Vulnerable persons according to article L.1121-6 of the CSP,
  • Persons of full age under guardianship or curatorship or under safeguard of justice,
  • Patient unable to personally give his or her consent, or age of majority protected by law,

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinique Néphrologique Saint Saint-Exupéry

Toulouse, 31077, France

Location

MeSH Terms

Conditions

Kidney Failure, ChronicRenal Insufficiency, Chronic

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 11, 2020

First Posted

May 22, 2020

Study Start

November 12, 2020

Primary Completion

June 4, 2022

Study Completion

June 4, 2022

Last Updated

November 16, 2022

Record last verified: 2022-06

Locations